Ehrlichiosis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Ehrlichiosis}}
{{Ehrlichiosis}}
{{PleaseHelp}}


==Natural History, Complications and Prognosis==


===Complications===
==Natural History==
Infection varies according to the Ehrlichiae agent responsible for the infection. Listed below are the progressive pathways of each infection:
 
===HGE===
====Early Stage====
*Sudden onset of fever with rigors
*Severe Myalgia
*Early Symptoms such as pain, nausea, vomiting, weight loss, cough, and confusion
 
====Late Stage====
*Toxic-like Syndrome
*ARDS
*Neurological disorders
*Liver complications
 
====If left untreated====
*Usually achieve a full recovery in 2 months
*Immuno-compromised individuals may suffer severe infections or even death as a result of an opportunistic co-infection.
 
 
===HME===
====Early Stage====
*Incubation of 7-10 days
*Initial presenting symptoms include fever, headache, and malaise.
*More severe infections will include myalgia, diaphoresis, weight loss, maculopapular rash, and confusion.
 
====Late Stage====
*Progression of symptoms requires hospitalization
*Majority of infected patients require intensive care
*Even with medical therapy 2.7% of infected patients die
 
====If left untreated====
*HME remains a life-threatening disease
*Without proper treatment patients may suffer from hypotension, respiratory failure, acute renal failure, and hemorrhagic manifestations
*Death
 
==Complications==
* [[Acute respiratory distress syndrome|Respiratory distress syndrome]]
* [[Acute respiratory distress syndrome|Respiratory distress syndrome]]
* [[Hepatitis]]
* [[Hepatitis]]
Line 15: Line 49:
* Opportunistic [[nosocomial infection]]s<ref>{{cite journal|last=Thomas|first=Rachael J|coauthors=Dumler, J Stephen, Carlyon, Jason A|title=Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and ehrlichiosis|journal=Expert Review of Anti-infective Therapy|date=1 August 2009|year=2009|month=August|volume=7|issue=6|pages=709–722|doi=10.1586/eri.09.44|pmid=19681699|pmc=2739015}}</ref>
* Opportunistic [[nosocomial infection]]s<ref>{{cite journal|last=Thomas|first=Rachael J|coauthors=Dumler, J Stephen, Carlyon, Jason A|title=Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and ehrlichiosis|journal=Expert Review of Anti-infective Therapy|date=1 August 2009|year=2009|month=August|volume=7|issue=6|pages=709–722|doi=10.1586/eri.09.44|pmid=19681699|pmc=2739015}}</ref>
* [[Death]]
* [[Death]]
==Prognosis==
===HGE===
*The prognosis for HGE is usually good.
*With proper treatment, patients should fully clear infection
*About Half of infected individuals will require 6 days of hospitalization 
*Even in the absence of treatment, infected patients should clear infection within 2 months
*Death associated with opportunistic co-infection.
===HME===
*HME is a severe illness with many complications
*Even in the presence of proper medical therapy, nearly 2.7% of infected patients will die
*Infection must be closely monitored in order to reduce the amount of possible complications


==References==
==References==

Revision as of 16:32, 18 January 2016

Ehrlichiosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ehrlichiosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

Ehrlichiosis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ehrlichiosis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ehrlichiosis natural history, complications and prognosis

CDC on Ehrlichiosis natural history, complications and prognosis

Ehrlichiosis natural history, complications and prognosis in the news

Blogs on Ehrlichiosis natural history, complications and prognosis

Directions to Hospitals Treating Ehrlichiosis

Risk calculators and risk factors for Ehrlichiosis natural history, complications and prognosis


Natural History

Infection varies according to the Ehrlichiae agent responsible for the infection. Listed below are the progressive pathways of each infection:

HGE

Early Stage

  • Sudden onset of fever with rigors
  • Severe Myalgia
  • Early Symptoms such as pain, nausea, vomiting, weight loss, cough, and confusion

Late Stage

  • Toxic-like Syndrome
  • ARDS
  • Neurological disorders
  • Liver complications

If left untreated

  • Usually achieve a full recovery in 2 months
  • Immuno-compromised individuals may suffer severe infections or even death as a result of an opportunistic co-infection.


HME

Early Stage

  • Incubation of 7-10 days
  • Initial presenting symptoms include fever, headache, and malaise.
  • More severe infections will include myalgia, diaphoresis, weight loss, maculopapular rash, and confusion.

Late Stage

  • Progression of symptoms requires hospitalization
  • Majority of infected patients require intensive care
  • Even with medical therapy 2.7% of infected patients die

If left untreated

  • HME remains a life-threatening disease
  • Without proper treatment patients may suffer from hypotension, respiratory failure, acute renal failure, and hemorrhagic manifestations
  • Death

Complications

Prognosis

HGE

  • The prognosis for HGE is usually good.
  • With proper treatment, patients should fully clear infection
  • About Half of infected individuals will require 6 days of hospitalization
  • Even in the absence of treatment, infected patients should clear infection within 2 months
  • Death associated with opportunistic co-infection.

HME

  • HME is a severe illness with many complications
  • Even in the presence of proper medical therapy, nearly 2.7% of infected patients will die
  • Infection must be closely monitored in order to reduce the amount of possible complications

References

  1. Thomas, Rachael J (1 August 2009). "Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and ehrlichiosis". Expert Review of Anti-infective Therapy. 7 (6): 709–722. doi:10.1586/eri.09.44. PMC 2739015. PMID 19681699. Unknown parameter |month= ignored (help); Unknown parameter |coauthors= ignored (help)